What living on a GLP-1 actually involves

Every common reaction with the trial rates from the labels, the serious warnings, and what changed in 2026.

Why side effects follow the dose more than the calendar, the dose-day rhythm, and when not to wait.

The most common side effect: how often it was reported, why it happens, what helps and when to call someone.

Why a slower gut causes it, what the 2025 nutrition advisory suggests, and the rare signs that are urgent.

How common it is, why fluids come first, and the signs that need a clinician.

Why a slower stomach brings them on, what helps, and the symptoms that need a doctor.

How often burping was reported, why it can smell of sulphur on a slower gut, and what helps.

Why fatigue is common in the first weeks, what feeds it, and when to get it checked.

How much more common they are than on placebo, the likely contributors, and the red flags.

Why a slower gut brings them on, what helps, and the signs of something more serious.

The link with blood pressure, fluids and blood sugar, and when dizziness needs a clinician.

How common it is, why the labels link it to weight loss, and what is known about regrowth.

Dysaesthesia: why it is linked to higher semaglutide doses and what the label reports.

What the FDA concluded in 2026, what the labels report now, and where to get help.

Insomnia, night-time reflux, and tirzepatide's approval for obstructive sleep apnoea.

The 2025 joint advisory in plain English: protein first, fibre, fluids, micronutrients and eating around side effects.

What the labels say about food and timing, why the tablets differ, and a practical plan for shot day.

Eating by the clock, easy protein for low days, and when too little becomes a problem.

What it means, why it goes quiet on a GLP-1, why it can return late in the week, and how to track it.

Why the labels stress fluids, how much the reference intakes suggest, and when electrolytes help.

Why it can worsen side effects, the low blood sugar risk, and what the craving research found.

Ordering for the stomach you have now: smaller, protein first, lighter cooking.

The building-up weeks, early side effects, and what to set up from day one.

Redness, bruises and lumps: how common they are, rotating sites, and skin to avoid.

Storage limits from each label, airport security, and what to ask about dose day abroad.

Why weight loss slows, when it flattened in the trials, and how to tell a plateau from daily noise.

What the body-composition scans show, and the protein and strength-training guidance.

What the stopping trials found, how the medicine clears, and what to plan with your prescriber.

Birth control pills, planning a pregnancy and breastfeeding — what each label says.

Six medicines by generic name: how each is taken, how long it lasts, and what it is approved for.

How they differ, the SURMOUNT-5 head-to-head trial, and side effects from the labels.

A one-week half-life, 5 to 7 weeks to clear, and what that means day by day.

A 5-to-6-day half-life, about a month to clear, and the larger swing within each week.

Daily versus weekly, and the STEP 8 head-to-head result.

Oral semaglutide and orforglipron versus weekly injections: routine, results, storage.

What they are, what the FDA has said, and how to keep a safe record.

45 terms from labels, trials and the pharmacy, explained plainly.

What the labels ask you to tell your prescriber, and the questions worth asking back. Printable checklist.

What a US prior authorization renewal may ask for, and the record that answers it.